Dima, D., Peres, L., Shune, L., Leitzinger, C., Reid, B., Portuguese, A., Cassano, R. C., Banerjee, R., Kalariya, N., Pasvolsky, O., Gaballa, M., Hunzeker, Z., Dillard, C., Hosoya, H., Mikkilineni, L., Gonzalez, R., Grajales-Cruz, A., Puglianini, O. A. C., Nishihori, T., Wagner, C., Cahoon, C., Sborov, D., Bhurtel, E., Kort, J., Geer, M., Purvey, S., Ferreri, C., Varga, C., Atrash, S., Voorhees, P., Goel, U., Khouri, J., Raza, S., Anwer, F., Afrough, A., Sannareddy, A., Anderson, L., Hassan, H., Herr, M., Reshef, R., Gordillo, C., Zolotov, E., Biran, N., Davis, J., Green, K., Zanwar, S., Lin, Y., Costa, L., Bal, S., Midha, S., Nadeem, O., Alsina, M., Baz, R., Shain, K., Locke, F., Kumar, S., Patel, K., Sidana, S., Hansen, D. (2025). Identifying candidates for outpatient administration of ciltacabtagene autoleucel (Cilta-cel) in relapsed-refractory multiple myeloma (RRMM). Blood. https://doi.org/10.1182/blood-2025-4000